Controlling SARS-CoV-2 in schools using repetitive testing strategies.
COVID-19
epidemic control
epidemiology
global health
human
infectious disease
microbiology
repetitive testing
Journal
eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614
Informations de publication
Date de publication:
05 07 2022
05 07 2022
Historique:
received:
15
11
2021
accepted:
15
06
2022
entrez:
5
7
2022
pubmed:
6
7
2022
medline:
7
7
2022
Statut:
epublish
Résumé
SARS-CoV-2 remains a worldwide emergency. While vaccines have been approved and are widely administered, there is an ongoing debate whether children should be vaccinated or prioritized for vaccination. Therefore, in order to mitigate the spread of more transmissible SARS-CoV-2 variants among children, the use of non-pharmaceutical interventions is still warranted. We investigate the impact of different testing strategies on the SARS-CoV-2 infection dynamics in a primary school environment, using an individual-based modelling approach. Specifically, we consider three testing strategies: (1)
Identifiants
pubmed: 35787310
doi: 10.7554/eLife.75593
pii: 75593
pmc: PMC9255973
doi:
pii:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2022, Torneri et al.
Déclaration de conflit d'intérêts
AT, LW, VC, CK, CM, GD, PL No competing interests declared, NH Reviewing editor, eLife
Références
Epidemiology. 2019 Sep;30(5):723-736
pubmed: 31274572
Ann Intern Med. 2021 Nov;174(11):1563-1571
pubmed: 34461034
Lancet Infect Dis. 2022 Jul;22(7):977-989
pubmed: 35378075
Lancet Microbe. 2021 Jan;2(1):e13-e22
pubmed: 33521734
Proc Natl Acad Sci U S A. 2021 Apr 27;118(17):
pubmed: 33827987
JAMA Intern Med. 2021 Mar 1;181(3):353-360
pubmed: 33449069
BMC Med. 2020 Jun 25;18(1):191
pubmed: 32586336
Nat Med. 2020 Aug;26(8):1205-1211
pubmed: 32546824
Health Care Manag Sci. 2021 Jun;24(2):305-318
pubmed: 33200374
Am J Respir Crit Care Med. 2020 May 1;201(9):1150-1152
pubmed: 32200654
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
JAMA Netw Open. 2021 Jun 1;4(6):e2116425
pubmed: 34170303
Nat Med. 2020 Aug;26(8):1200-1204
pubmed: 32555424
BMC Med. 2021 Sep 29;19(1):254
pubmed: 34583683
N Engl J Med. 2020 Sep 24;383(13):1283-1286
pubmed: 32857487
Sci Rep. 2021 Jul 6;11(1):13903
pubmed: 34230530
Nat Commun. 2022 Mar 1;13(1):1106
pubmed: 35232987
Science. 2021 Jan 15;371(6526):
pubmed: 33234698
Int J Infect Dis. 2020 Jul;96:288-290
pubmed: 32437933
PLoS Comput Biol. 2021 Mar 29;17(3):e1008892
pubmed: 33780436
Lancet Infect Dis. 2020 Jun;20(6):656-657
pubmed: 32199493
Environ Int. 2020 Aug;141:105794
pubmed: 32416374
BMC Med. 2022 Feb 18;20(1):80
pubmed: 35177062
PLoS Comput Biol. 2021 Mar 9;17(3):e1008688
pubmed: 33690626
Lancet Respir Med. 2020 May;8(5):446-447
pubmed: 32224304
Lancet Respir Med. 2021 Aug;9(8):e85
pubmed: 34265238
Nature. 2020 Dec;588(7836):E6
pubmed: 33199918
Int J Infect Dis. 2020 Jun;95:441-443
pubmed: 32376309
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
Arch Dis Child. 2021 Dec;106(12):1147-1148
pubmed: 33402324
JAMA Netw Open. 2021 Oct 1;4(10):e2128757
pubmed: 34636913
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168